EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Independent prognostic value of peak width of skeletonized mean diffusivity on clinical progression in Alzheimer's disease

Jonas Alexander Jarholm, Sandra Tecelão, Bjørn‐Eivind Kirsebom, Mostafa Mehdipour Ghazi, Lene Pålhaugen, Berglind Gísladóttir, Fernando Gonzalez‐Ortiz, Mehdi Sadat Akhavi, Einar Hopp, Anders Martin Fjell, Santiago Timón‐Reina, Mads Nielsen, Kaj Blennow, Dag Aarsland, Atle Bjørnerud, Per Selnes, Tormod Fladby

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2026-07 · 18 (3)

DOI: 10.1002/dad2.70416 ↗
AbstractBibliografische Angaben

Abstract

Abstract INTRODUCTION Peak width of skeletonized mean diffusivity (PSMD) is a candidate magnetic resonance imaging marker for global white matter integrity. We investigated the value of PSMD in predicting clinical progression in amyloid‐positive and amyloid‐negative individuals. METHODS PSMD, cognition, and amyloid status were measured in 254 subjects from the Dementia Disease Initiation (DDI) cohort and 211 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Survival analysis was conducted on 166 DDI subjects and validated in 178 ADNI subjects using Clinical Dementia Rating scale. RESULTS High PSMD amyloid‐positive individuals had an increased risk of clinical progression relative to those with low PSMD, driven by independent additive effects of amyloid pathology and PSMD. Higher PSMD was predominantly associated with slower processing speed and reduced executive function, but not with memory performance. DISCUSSION Combining PSMD with amyloid status may improve the prediction of clinical progression in Alzheimer's disease, particularly in relation to executive and processing speed domains.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →